Atlas Trials

EGFR and/or ROS Mutant NSCLC

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR and/or ROS Mutant NSCLC

RecordFirmDate
A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. (NCT01219543)AstraZeneca2010-11-01

Track EGFR and/or ROS Mutant NSCLC automatically

Every clearance here is in the API, with alerts when new ones post.